Literatur
- 1
Parrilla P, Martinez de Haro L F, Ortiz A, Munitiz V.
Standard antireflux operations in patients who have Barrett’s esophagus. Current
results.
Chest Surg Clin N Am.
2002;
12
113-126
- 2
Parilla P, Martinez de Haro L F, Ortiz A, Munitiz V, Moina J, Bermejo J, Canteras M.
Long-term results of a randomized prospective study comparing medical and surgical
treatment of Barrett’s esophagus.
Ann Surg.
2003;
237
291-298
- 3
Spechler SJ, Lee E, Ahnen D, Goyal R K, Hirano I, Ramirez F, Raufman J P, Sampliner R,
Schnell T, Sontag S, Vlahcevic Z R, Young R, Williford, W.
Long-term outcome of medical and surgical therapies for gastroesophageal reflux
disease: follow-up of a randomized controlled trial.
JAMA.
2001;
285
2331-2338
- 4
Deer C A. et al .
The economics of laparoscopic fundoplicatio.
Gastroenterol Hepatol.
2003;
1
328-332
- 5
Avidan B, Sonnenberg A, Schnell TG, Sontag S J.
There are no reliable symptoms for erosive oesophagitis and Barrett’s oesophagus:
endoscopic diagnosis is still essential.
Aliment Pharmacol Ther.
2002;
16
735-742
- 6
Amin M R, Postma G N, Johnson P, Digges N, Koufman J A.
Proton pump inhibitor resistance in the treatment of laryngopharygeal reflux.
Otolaryngol Head Neck Surg.
2001;
125
374-378
- 7
Bais J E, Bartelsman J F, Bonjer H J, Cuesta M A, Go P M, Klinkenberg-Knol E C, van
Lanschot J J, Nadorp JH, Smout A J, van der Graaf Y, Gooszen H G. The Netherlands
Antireflux Surgery Study Group .
Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux
disease: randomised clinical trial.
Lancet.
2000;
355
170-174
- 8 Bollschweiler E. Nationale und klinikinterne Leitlinien: Definition und Problemlage. Schattauer-Verlag
Stuttgart In: Lauterbach KW, Schrappe M (Hrsg) Gesundheitsökonomie, Qualitätsmanagement
und Evidence-based Medicine 2001: 457-462
- 9
Campos G M, Peters J H, DeMeester T R, Oberg S, Crookes P F, Tan S, DeMeester S R,
Hagen J A, Bremner C G.
Multivariate analysis of factors predicting outcome after laparoscopic Nissen
fundoplication.
J Gastrointest Surg.
1999;
3
292-300
- 10
Carlson M A, Frantzides C T.
Complications and results of primary minimally invasive antireflux procedures:
a review of 10(735 reported cases.
J Am Coll Surg.
2001;
193
428-439
- 11
Corley D A, Levin T R, Habel L A, Weiss N S, Buffler P A.
Surveillance and survival in Barrett’s adenocarcinoma: a population-based study.
Gastroenterology.
2002;
122
633-640
- 12
Csendes A, Burdiles P, Korn O, Braghetto I, Huertas C, Rojas J.
Late results of a randomized clinical trial comparing total fundoplication versus
calibration of the cardia with posterior gastropexy.
Br J Surg.
2000;
87
289-297
- 13
Dent J, Brun J, Fendrick A M, Fennerty M B, Janssens J, Kahrilas P J, Lauritsen K,
Reynolds J C, Shaw M, Talley N J. on behalf of the Genval Workshop Group .
An evidence-based appraisal of reflux disease management - the Genval Workshop
Report.
Gut.
1999;
44
(Suppl 2)
S1-16
- 14
Dent J.
Controversies in long-term management of reflux disease.
Baillère’s Clinical Gastroenterology.
2000;
14
811-826
- 15
Deschamps C, Allen M S, Trastek V F, Johnson J O, Pairolo P C.
Early experience and learning curve associated with laparoscopic Nissen fundoplication.
J Thorac Cardiovasc Surg.
1998;
115
281-284
- 16
Devière J, Pastorelli A, Louis H, de Maertelaer V, Lehman G, Cicala M, Le M oine O,
Silverman D, Costamagna G.
Endoscopic implantation of a biopolymer in the lower esophageal sphincter for
gastroesophageal reflux: a pilot study.
Gastrointest Endosc.
2002;
55
335-341
- 17
Edwards S J, Lind T, Lundell L.
Systematic review of proton pump inhibitors for the acute treatment of reflux
oesophagitis.
Aliment Phamacol Ther.
2001;
15
1729-1736
- 18
Farrell T M, Richardson W S, Trus T L, Smith C D, Hunter J G.
Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery.
Br J Surg.
2001;
88
1649-1652
- 19
Fibbe C, Layer P, Keller J, Strate U, Emmermann A, Zornig C.
Esophageal motility in reflux disease before and after fundoplication: A prospective,
randomized, clinical, and manometric study.
Gastroenterology.
2001;
121
5-14
- 20
Fuchs K H, Tigges H, Heimbucher J, Freys S M, Thiede A.
Laparoskopische Eingriffe bei gastroösophagealer Refluxkrankheit - eine Nutzen-Kosten-Analyse.
Zentralbl Chir.
1997;
122
1072-1077
- 21
Galmiche J P, Zerbib F.
Antagonist: Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal
reflux disease.
Gut.
2002;
51
472-474
- 22
Hadorn D C, Baker D.
Development of the AHCPR-sponsored heart failure guideline: methodologic and
procedural issues.
Jt Comm J Qual Improv.
1994;
20
539-547
- 23
Hagedorn C, Lonroth H, Rydberg L, Ruth M, Lundell L.
Long-term efficacy of total (Nissen-Rossetti) and posterior partial (Toupet)
fundoplication: Results of a randomized clinical trial.
J Gastrointest Surg.
2002;
6(4
540-545
- 24
Heudebert G R, Marks R, Wilcox M, Centor R M.
Choice of long-term strategy for the management of patients with severe esophagitis:
a cost-utility analysis.
Gastroenterology.
1997;
112
1078-1086
- 25
Hölscher A H, Blum A L.
Chirurgische und medikamentöse Therapie der gastroösophagealen Refluxkrankheit
- Konsens einer Pro- und Contra-Diskussion.
Z Gastroenterol.
2003;
41
729-732
- 26
Hüttl T P, Hohle M, Meyer G, Schildberg F W.
Antireflux surgery in Germany: Results of a representative survey with analysis
of 2,540 antireflux operations.
Chirurg.
2002;
73
451-461
- 27
Inadomi J M, Jamal R, Murata G H, Hoffman R M, Lavezo L A, Vigil J M, Swanson K M,
Sonnenberg A.
Step-down management of gastroesophageal reflux disease.
Gastroenterology.
2001;
121
1095-1100
- 28
Jones M P, Sloan S S, Rabine J C, Ebert C C, Huang C F, Kahrilas P J.
Hiatal hernia size is the domiant determinant of esophagitis presence and severity
of gastroesophageal reflux disease.
A J Gastroenterol.
2001;
96
1711-1717
- 29
Kahrilas PJ.
Management of GERD: Medical versus surgical.
Seminars in Gastrointestinal Disease.
2001;
12
3-15
- 30
Kahrilas PJ.
Surgical therapy for reflux disease.
JAMA.
2001;
285
2376-2378
- 31
Khajanchee Y S, O’Rourke R W, Lockhart B, Patterson E J, Hansen P D, Swanstrom L L.
Postoperative symptoms and failure after antireflux surgery.
Arch Surg.
2002;
137
1008-1013
- 32
Klaus A, Hinder R A.
Medical therapy versus antireflux surgery in Barrett’s esophagus: what is the
best therapeutic approach?.
Dig Dis.
2000 - 2001;
18
224-231
- 33
Kleinmann E, Halbfass H J.
Zur Problematik des „short esophagus” in der laparoskopischen Antirefluxchirurgie.
Chirurg.
2001;
72
408-413
- 34
Klinkenberg Knol E C, Festen H P, Jansen J B, Lamers C B, Nelis F, Snel P, Luckers A,
Dekkers C P, Havu N, Meuwissen S G.
Long term treatment with omeprazole for refractory reflux esophagitis: efficacy
and safety.
Ann Intern Med.
1994;
121
161-167
- 35
Klinkenberg Knol E C, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N,
Frame M H, Roman J, Walan A, Group L T.
Long term omeprazole treatment in resistant gastroesophageal reflux disease:
efficacy, safety, and influence on gastric mucosa.
Gastroenterology.
2000;
118
661-669
- 36
Leeder P C, Watson D I, Jamieson G G.
Laparoscopic fundoplication for patients with symptoms but no objective evidence
of gastroesophageal reflux.
Dis Esoph.
2002;
15
309-314
- 37
Lundell L, Miettinen P, Myrvold H E, Pedersen S A, Liedmann B, Hatlebakk J G, Julkonen R,
Carlsson J, Lamm M, Wiklund I.
Continued (5 year) followup of a randomized clinical study comparing antireflux
surgery and omeprazole in gastroesophageal reflux disease.
J Am Coll Surg.
2001;
192
172-181
- 38
Lundell L.
Protagonist: Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal
reflux disease.
Gut.
2002;
51
468-471
- 39
Martinez S D, Malagon IB, Garewal H S, Cui H, Fass R.
Non-erosive reflux disease (NERD) B acid reflux and symptom patterns.
Aliment Phamacol Ther.
2003;
17
537-545
- 40
Maziak D E, Todd T RJ, Pearson F G.
Massive hiatus hernia: evaluation and surgical management.
J Thorac Cardiovasc Surg.
1998;
115
53-62
- 41
Menon V S, Manson J M, Baxter J N.
Laparascopic fundoplicaion: learning curve and patient satisfaction.
Ann R Coll Surg Engl.
2003;
85
10-13
- 42
Myrvold H E, Lundell L, Miettinen P, Pedersen S A, Liedman B, Hatlebakk J, Julkunen R,
Levander K, Lamm M, Mattson C, Carlsson J, Stahlhammar N O. and the Nordic GORD Study
Group .
The cost of long term therapy for gastro-oesophageal reflux disease: a randomised
trial comparing omeprazole and open antireflux surgery.
Gut.
2001;
49
488-494
- 43
Neuhauser B, Bonatti H, Hinder R A.
Strategien zur Behandlung der gastroösophagealen Refluxkrankheit.
Chirurg.
2003;
74
617-625
- 44
O’Boyle C J, Watson D I, DeBeaux A C, Jamieson G G.
Preoperative prediction of long-term outcome following laparoscopic fundoplication.
ANZ J Surg.
2002;
2
471-475
- 45
O’Connor J B, Provenzale D, Brazer S.
Economic considerations in the treatment of gastroesophageal reflux disease:
a review.
Am J Gastroenterol.
2000;
95
3356-3364
- 46
Ortiz A, Martinez de Haro L F, Parrilla P, Morales G, Molina J, Bermejo J, Liron R,
Aguilar J.
Conservative treatment versus antireflux surgery in Barrett’s oesophagus: long
term results of a prospective study.
Br J Surg.
1996;
83
274-278
- 47
Peghini P G, Katz P O, Castell D O.
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled
study in normal subjects.
Gastroenterology.
1998;
115
1335-1339
- 48
Peters J H, Silverman D E, Stein A.
Lower esophageal sphincter injection of a biocompatible polymer.
Surg Endosc.
2003;
, (Feb 17, epub ahead of print, to be completed in galley proof)
- 49
Peters F T, Ganesh S, Kuipers E J, Sluiter W J, Klinkenberg-Knol E, Lamers C B, Kleibeuker J H.
Endoscopic regression of Barrett’s oesophagus during omeprazole treatment: a
randomised double blind study.
Gut.
1999;
45
489-494
- 50
Rantanen T K, Halme T V, Luostarinen M E, Karhumaki LM, Kononen EO, Isolauri J O.
The long term results of open antireflux surgery in a community-based health
care center.
Am-J-Gastroenterol.
1999;
94
177717-81
- 51
Reilly J P.
Safety profile of the proton-pump inhibitors.
Am J Health Syst Pharm.
1999;
56
(Suppl 4)
S11-17
- 52
Romagnuolo J, Meier M A, Sadowski D C.
Medical or surgical therapy for erosive reflux esophagitis: cost utility analysis
using a Markov model.
Ann Surg.
2002;
236
191-202
- 53
Rydberg L, Ruth M, Abrahamsson H, Lundell L.
Tailoring antireflux surgery: A randomized clinical trial.
World J Surg.
1999;
23
612-618
- 54
Schäfer H, Collet P, Wolfgarten E, Gutschow Chr, Hölscher A H.
Endoskopische Gastroplastik zur Behandlung der gastroösophagealen Refluxerkrankung
( eine Pilotstudie.
Visceralchirurgie.
2001;
36
362-366
- 55
Sonnenberg A.
Motion ( laparoscopic Nissen fundoplication is more cost effective than oral
PPI administration: arguments against the motion.
Can J Gastroenterol.
2002;
16
627-631
- 56
Stylopoulos N, Gazelle G S, Rattner D W.
Paraesophageal hernias: operation or observation.
AnnSurg.
2002;
236
492-501
- 57
Swanström L L.
Motion - laparoscopic Nissen fundoplication is more cost effective than oral
PPI administration: arguments for the motion.
Can J Gastroenterol.
2002;
16
621-623
- 58
Taha A S, Angerson W J, Morran C G.
Reflux and Barrett(s oesophagitis after gastric surgery - long-term follow-up
and implications for the roles of gastric acid and bile in oesophagitis.
Aliment Pharmacol Ther.
2003;
17
547-552
- 59
Tan L C, Samanta S, Hosking S W.
Safe transition from open to laparascopic fundoplication by an established consultant
( the importance of repeated audit.
Ann R Coll Surg Engl.
2002;
84
84-88
- 60
Thjodleifsson B, Rindi G, Fiocca R, Hmphries T J, Morocutti A, Miller N, Bardhan .
A randomized double blind trial of the efficacy and safety of 10 or 20 mg rabeprazole
compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux
disease over 5 years.
liment Pharmacol Ther.
2003;
17
343-351
- 61
Vakil N, Shaw M, Kirby R.
Clinical effectiveness of laparoscopic fundoplication in a US community.
Am J Med.
2003;
1114
1-5
- 62
Van der Peet D L, Klinkenberg-Knol E C, Eijsbouts Q AJ, van den Berg M, de Brauw L M,
Cuesta M A.
Laparoscopic Nissen fundoplication for the treatment of gastroesophageal reflux
disease (GERD): surgery after extensive conservative treatment.
Surg Endosc.
1998;
1
1159-1116
- 63
Vela M F, Camacho Lobato L, Srinivasan R, Tutuian R, Katz P O, Castell D O.
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid
gastroesophageal reflux: effect of omeprazole.
Gastroenterology.
2001;
120
1599-1606
- 64
Viljakka M, Nevalainen J, Isolauri J.
Lifetime costs of surgical versus medical treatment of severe gastrooesophgeal
reflux disease in Finland.
Scand J Gastroenterol.
1997;
32
766-772
- 65
Wolfsen H C, Richards W O.
The Stretta procedure for the treatment of GERD: a registry of 558 patients.
J Laparoendosc Adv Surg Tech.
2002;
12
395-402
- 66
Ye W, Chow W H, Lagergren J, Yin L, Nyren O.
Risk of adenocarcinomas of the esophagus and gastric cardia in patients with
gastroesophageal reflux diseases and after antireflux surgery.
Gastroenterology.
2001;
121
1286-1293
- 67
You J H, Lee A C, Wong S C, Chan F K.
Low-dose or standard-dose proton pump inhibitors for maintenance therapy of
gastro-oesophageal reflux disease: a cost-effectiveness analysis.
Aliment Phrmacol Ther.
2003;
17
785-792
Prof. Dr. W. Rösch
Medizinische Klinik am Krankenhaus Nordwest der Stiftung Hospital zum Heiligen
Geist
Steinbacher Hohl 2-26
60488 Frankfurt
